Aviceda Therapeutics
Operator of a biotechnology company intended to develop breakthrough glycol-therapeutics for patients. The company combines biology with a cell-based screening platform and proprietary nanoparticle te...
Valuation
$346.5M
Latest known
Share Price
N/A
Total Raised
$276.3M
Last Round
N/A